Report shows investments save lives and dollars
The U.S. government invested $12.7 billion over the past decade in the creation of new vaccines, drugs, diagnostics and other products for neglected diseases in the developing world. That’s according to a new report released by the Global Health Technologies Coalition (GHTC) and Policy Cures on Friday.
Of the 45 new products registered in that time to address these neglected diseases that affect more than 1 billion people around the world, the U.S. was involved in the development of 24 of them (or 52 percent).
Stephen Lawn reminded the audience at the International Treatment as Prevention Workshop in Vancouver on Wednesday that antiretroviral therapy (ART) goes a long way to protect HIV-infected individuals from tuberculosis (TB). The HIV-associated TB epidemic requires “radical interventions,” according to Lawn. “DOTS [directly observed TB therapy, short course] just isn’t doing it.” He called the […]
Jim Yong Kim MD, PhD (Photo Courtesy: National Institutes of Health) The Executive Directors of the World Bank met in Washington, DC, Monday – and announced their selection of Jim Kim, MD, PhD, as the 12th president of the poverty-reduction organization. Kim’s five-year term will start on July 1, when he succeeds current president Robert […]
Global health groups reached out to the Medicines Control Council (MCC) in South Africa Thursday advocating “compassionate use” of an exploratory multidrug-resistant tuberculosis (MDR-TB) treatment known as TMC-207 or bedaquiline. The compassionate use concept allows patients access to promising new drug candidates in clinical trials when current treatment options have proven unsuccessful and is endorsed […]
Global health researchers early on in their careers now have a new opportunity for mentored research in a developing country. The National Institutes of Health (NIH) announced Wednesday a new effort to award $20.3 million over the next five years to 400 physicians, veterinarians, dentists and scientists on nearly year-long fellowships at approximately 80 sites […]
Science Speaks continues its interview series exploring the global HIV and tuberculosis research and development efforts at the U.S. Centers for Disease Control and Prevention (CDC) with a conversation with Bess Miller, MD, MSc, who works in the Division of Global HIV/AIDS. Dr. Miller has served as associate director and team lead for HIV/TB, providing leadership in policy and implementation of TB/HIV activities in 43 resource-limited countries supported by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). She has worked to align PEPFAR TB/HIV priorities with the World Health Organization (WHO) policies on TB/HIV, and on the use of antiretroviral therapy (ART) in people living with HIV (PLHIV). In this interview Dr. Miller discusses the successes and challenges in implementing TB infection control in Africa, progress in deploying the GeneXpert MTB/RIF rapid TB diagnostic on the ground there, and how efforts to scale up access to ART are helping achieve goals in TB control and elimination.
Dr. Christoph Benn, director of Resource Mobilization and Donor Relations at the Global Fund to Fight AIDS, Tuberculosis and Malaria, updated global health community advocates Wednesday on the recent tumult at the multilateral organization. Since Columbian banker Gabriel Jaramillo was appointed to head up the Fund in January, the Secretariat has been consumed with “internal […]
The U.S. Department of Health and Human Services (HHS) released updated HIV treatment guidelines on March 27 which, among other things, maintain that all people living with HIV in the U.S. are now eligible to receive antiretroviral therapy (ART), regardless of CD4 cell count. Previous guidance recommended ART for those HIV-infected with a CD4 cell […]
Former tuberculosis (TB) patients from around the world offered a unique glimpse at the impact of the disease on individuals, and the toll it takes on family and friends, by telling their personal stories at an event hosted by The U.S. Agency for International Development (USAID) in late March to honor World TB Day. “Too often we focus on the tragedy – […]